Xcell Therapeutics is a company that develops and provides products and services for cell culture and regenerative medicine. Their core product, CellCor, is a serum-free and chemically defined media for cell culture, which provides an optimal environment for cell growth and research. The company is focused on developing innovative technologies for cell therapy, including automated mass cell culture systems, exosome research, and clonal selection of mesenchymal stem cells. Xcell Therapeutics aims to provide cost-effective and eco-friendly solutions for researchers and developers in the regenerative medicine market, with a goal of advancing the field of cell therapy and contributing to the development of new treatments.

Since our inception in 2015, Xcell Therapeutics’ focus has been to create a better future for humanity through the application and use of ethical science. With 10 years of research, we have made a breakthrough and developed CellCor™, a serum free chemically defined media composed of over 200 known compounds. CellCor™ does not contain any animal nor plant derived components, making it a pure CD media.

Today, we are working with a team of talented researchers in the R&D section. We are currently working on developing proliferation media for various animal cell types. Our research team guarantees to use ethical technologies and tools for our research.

It is our goal to become the CDMO leader in regenerative medicine within the next 10 years and build a world where innovation in life sciences is as ethical as it is revolutionary.

CellCor™ is our First-in-Class MSC pipeline consist of serum-free defined and serum-free chemically defined products. CellCor™ provides an optimal environment for cell culture, contenting researchers with the best results and efficiency. Get your therapies going with CellCor™